EFFECTS OF AN ORALLY ACTIVE ANGIOTENSIN ANTAGONIST, LOSARTAN, ON THE CHRONICALLY CATHETERIZED SHEEP FETUS

被引：0

作者：

LUMBERS, ER ^{[1
]}

STEVENSON, KM ^{[1
]}

机构：

[1] UNIV NSW,SCH PHYSIOL & PHARMACOL,SYDNEY,NSW 2033,AUSTRALIA

来源：

FASEB JOURNAL | 1993年 / 7卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A445 / A445

页数：1

共 50 条

[21] EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN V(1)-RECEPTOR ANTAGONIST
BURRELL, LM
PHILLIPS, PA
STEPHENSON, J
RISVANIS, J
HUTCHINS, AM
JOHNSTON, CI
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1993, 20 (05) : 388 - 391
[22] HEMODYNAMIC AND HUMORAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN ESSENTIAL-HYPERTENSION
GROSSMAN, E
PELEG, E
CARROLL, J
SHAMISS, A
ROSENTHAL, T
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) : 1041 - 1044
[23] EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN HYPERTENSIVE PATIENTS WITH RENAL-DISEASE
GANSEVOORT, RT
DEZEEUW, D
SHAHINFAR, S
REDFIELD, A
DEJONG, PE
JOURNAL OF HYPERTENSION, 1994, 12 : S37 - S42
[24] Effects of angiotensin II and the AT1 receptor antagonist losartan on the renal excretion of urodilatin
Heringlake, M
Bahlmann, L
Klaus, S
Wagner, K
Schmucker, P
Pagel, H
KIDNEY & BLOOD PRESSURE RESEARCH, 2001, 24 (02) : 79 - 83
[25] Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
Lo, MW
Goldberg, MR
McCrea, JB
Lu, H
Furtek, CI
Bjornsson, TD
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) : 641 - 649
[26] LOSARTAN - AN ORALLY ACTIVE ANGIOTENSIN-II ANTAGONIST - PROCEEDINGS OF A MEETING HELD IN ST-PAUL-DE-VENCE, FRANCE 26-27 JUNE 1992 - INTRODUCTION
SWEET, CS
JOURNAL OF HYPERTENSION, 1993, 11 : S1 - S1
[27] Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport
Hatch, M
Freel, RW
Shahinfar, S
Vaziri, ND
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 276 (01) : 187 - 193
[28] Effects of angiotensin Ⅱ receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells
Wen-Bin Liu
World Journal of Gastroenterology, 2005, (41) : 6489 - 6494
[29] RENAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN VOLUNTEERS ON A LOW AND HIGH SODIUM DIET
BURNIER, M
RUTSCHMAN, B
NUSSBERGER, J
WAEBER, B
SHAHINFAR, S
VERSAGGI, J
BRUNNER, HR
CIRCULATION, 1992, 86 (04) : 545 - 545
[30] HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN PATIENTS WITH HEART-FAILURE
DICKSTEIN, K
GOTTLIEB, S
FLECK, E
KOSTIS, J
LEVINE, B
DEKOCK, M
LEJEMTEL, T
JOURNAL OF HYPERTENSION, 1994, 12 : S31 - S35

← 1 2 3 4 5 →